Imaging Flow Cytometry Market Size, Share, Trends, Industry Analysis & Growth 2032

Imaging Flow Cytometry Market Insights

According to the report published by Zion Market Research, the global Imaging Flow Cytometry Market size was valued at USD 212.63 Million in 2023 and is predicted to reach USD 597.74 Million by the end of 2032. The market is expected to grow with a CAGR of 12.17% during the forecast period. The report analyzes the global Imaging Flow Cytometry Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Imaging Flow Cytometry industry.

Request Free Sample

Global Imaging Flow Cytometry Market: Overview

Flow cytometry helps in isolating, characterizing, and identifying stem cells for research activities owing to their ability to perform effective quantitative measurements on a cell within the given heterogeneous cell population. It is a media for the complex characterization of cells. The flow cytometer can also be viewed as a microscope with spatial resolution. It is also known as multispectral imaging flow cytometry. Imaging flow cytometry uses multi-channel views of cells. It allows morphometric characterization of the cell to fluorescent imaging in an attachment.

Global Imaging Flow Cytometry Market: Growth Factors

The growing focus on immune-oncology & immunology research activities and surge in adoption of flow cytometry methods in clinical trials and research activities are some of the major factors driving the growth of the global imaging flow cytometry market. In addition, the software known as IDEAS refers to the analysis that is required to be implemented while using tools that are well familiar with flow cytometric like dot plots and histograms facilitating instant morphological analysis. Imaging flow cytometry is highly helpful in characterizing and recognizing a small population of cells like a low percentage of a cell population that build an immune snap in the research of CTL morphology interaction of HIV infection. A large number of applications can be executed with the help of imaging flow cytometry including nuclear translocation, immune synapse, formation modification & morphological cells, and binding of two cells.

The surge in the utilization of allogeneic and autologous stem cells treatment by healthcare professionals owing to the unfavorable radiation's effect along with the chemotherapy for the treatment of diseases like cancer is expected to significantly drive the growth of global imaging flow cytometry market in the forthcoming years. The growing accessibility of novel applications in specific flow cytometry is another key reason driving the growth of the market. The ongoing technological advancements will improve the cost-effectiveness, portability, and accuracy of the cytometry techniques. Manufacturers are emphasizing innovations in the market to explore the untapped potential. Also, the growing inclusion of artificial intelligence platforms in flow cytometry workflow will further fuel the growth of the global imaging flow cytometry market. However, the growing prevalence of targeted diseases along with advancements in life science research is likely to expedite the demand for flow cytometry in the market.

The fast proliferating biotechnology sector globally is likely to exhibit huge potential for the development of flow cytometry techniques. It will also help in improving the healthcare facility. Also, it is widely utilized in conducting clinical trials associated with in-vitro molecular diagnostics. Furthermore, the growing investments from government, biotech, pharma, and biopharma companies are likely to further widen the scope of imaging flow cytometry globally.

Request Free Sample

Global Imaging Flow Cytometry Market: Segmentation

The global imaging flow cytometry market can be segmented into end-user, application, technology, product, and region.

By end-user, the market can be segmented into pharmaceutical & biotechnology companies, academics & research institutes, hospitals, clinics, and other end users. The hospital segment accounts for the largest share in the global imaging flow cytometry market due to the growing facility in hospital centers.

By application, the market can be segmented into hematology, organ transplantation, stem cell therapy, drug discovery, oncology, and other applications.

By technology, the market can be segmented into bead-based and cell-based flow cytometry.

By product, the market can be segmented into software & services, kits & reagents, instruments, and other products.

Imaging Flow Cytometry Market: Report Scope

Global Imaging Flow Cytometry Market: Regional analysis

North America accounts for the largest share in the global imaging flow cytometry market. The growth can be attributed to the growing healthcare expenditure in the region along with the well-established healthcare infrastructure. The high adoption of advanced flow cytometer solutions in the region is further likely to propel the growth of the regional market. The ongoing research activities by universities and pharmaceutical companies are creating several growth opportunities for imaging flow cytometry solutions in the region. However, the growing prevalence of infectious and chronic diseases in the region will accentuate the growth of the regional market. The outbreak of the Covid-19 pandemic has significantly scaled the demand for imaging flow cytometry solutions for research and diagnostics purposes.

Asia Pacific is expected to grow significantly with a high CAGR due to the fast proliferating biotechnology and pharmaceutical sector in the region. The growing economies like India and China are posing the huge potential for the growth of the regional market. The outbreak of the Covid-19 is significantly creating several lucrative growth opportunities in the regional market. Also, the growing funding and research & development activities in the field of infectious disease and cancer treatment are further likely to widen the scope of imaging flow cytometry solutions in the region.

Global Imaging Flow Cytometry Market: Competitive Players

Some of the significant players in the global imaging flow cytometry market are:

• Miltenyi Biotec
• Stratedigm
• Thermo Fisher
• Apogee
• Agilent Technologies
• Sysmex
• Coriolis Pharma
• Merck Group
• Danaher Corporation
• Luminex Corporation.

The Global Imaging Flow Cytometry Market is segmented as follows:

By end-user 

• pharmaceutical & biotechnology companies
• academics & research institutes
• hospitals, clinics
• other end users

By application 

• hematology 
• organ transplantation
• stem cell therapy
• drug discovery
• oncology 
• and other applications

By technology 

• bead-based
• cell-based flow cytometry 

By product 

• software & services
• kits & reagents
• instruments
• and other products

Global Imaging Flow Cytometry Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.